BMRA

Conviction 3HealthcareScan · Fri, Jun 26, 2026

Bullish marubozu

BMRA$1.78+1.43%

ResistanceSupportVol 14

Vol MA14 22.39K

Mar 27Apr 15May 4May 20Jun 9Jun 26

BIOMERICA INCIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.biomerica.com ↗

Price1.78

Change+1.43%

Gap+0.29%

Rel volume1.17×

Avg volume20.9K

Avg $ vol41.57K

SMA 202.01

SMA 502.16

SMA 2002.39

Price vs 50-17.86%

Price vs 200-25.89%

MA stackbearish

50/200 cross—

Supertrenddown · 2.14

RSI (14)32

MACD hist-0.03

MACD cross—

Stoch %K / %D8 / 5

ADX (14)14

+DI / −DI18 / 24

RSI divergence—

MACD divergence—

ATR %+7.16%

ADR %6.53%

52w high4.14

52w low1.75

From 52w high-57.13%

Above 52w low+1.43%

New 52w highNo

SqueezeOff

Bollinger width36.81%

%B0.18

Donchian pos6.17%

Donchian high2.46

Donchian low1.73

AVWAP (52w high)3.48

vs AVWAP high-48.96%

AVWAP (52w low)1.77

vs AVWAP low+0.47%

OBV trendDown

Chaikin MF (20)-0.57

Today vs 20d1.17×

Avg vol (14d)22.39K

Avg vol (20d)20.9K

Avg $ vol (20d)41.57K

Market cap—

RS 3m (vs SPY)-30.78%

RS 6m (vs SPY)-33.38%

RS line new highNo

Trend template0/8

Technical rank12.9

1 week-0.84%

1 month-27.70%

3 months-15.88%

6 months-32.25%

1 year-43.29%

YTD-29.84%

P/E-1.10

P/B1.64

P/S1.03

P/FCF-1.40

EPS-2.16

Div yield—

ROE-149.92%

ROA-101.95%

Debt/Eq—

Current2.64

EV/EBITDA-0.81

Gross margin9.38%

Net margin-93.64%

Rev growth-1.92%

EPS growth16.81%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value4.12M

Revenue987K

Net income-1.31M

Gross profit-44K

Free cash flow-3.89M

IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

ExchangeNasdaq

Shares out3.09M

Employees54

ListedTue, Sep 26, 1978

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction3 / 100

Pattern quality—

Tech rank12.9 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish marubozu

News sentiment—

Financials as of Sat, Feb 28, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BMRA

All disclosures →

No recent disclosed trades by Congress in BMRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BMRA

No recent insider (Form 4) filings in BMRA. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in BMRA · 1 recent

EDGAR →

8-K8-KThu, Jun 4, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.